Healthcare Industry News: HSMN NewsFeed
News Release - April 30, 2012
Toshiba’s Aquilion PRIME 80 CT System Receives FDA ClearanceNew CT System Features AIDR 3D, Faster Reconstruction and Lower-Dose Exams
TUSTIN, Calif.--(Healthcare Sales & Marketing Network)--Toshiba America Medical Systems, Inc. announces the FDA clearance of the Aquilion(TM) PRIME 80 series CT system, the latest addition to the Aquilion CT product line. Producing high-quality clinical images and reducing radiation exposure with Adaptive Iterative Dose Reduction 3D (AIDR 3D), the system can generate 80 unique slices per rotation. The Aquilion PRIME 80 series, designed with in-field upgradeability to 160 slices, gives healthcare facilities the ability to perform a wide variety of advanced clinical procedures today and to grow as clinical needs expand.
The Aquilion PRIME features a 0.5 mm detector, a 7.5 MHU large-capacity tube and 0.35 second scanning. This high-speed rotation allows rapid data acquisition and shortens scan times while the fast reconstruction unit further improves throughput, all of which help provide faster, safer and more accurate diagnoses. The system also features a 78 cm aperture gantry, the largest currently available in a high-end CT system. The combination of a 660-pound patient-weight-capacity couch with a large gantry bore makes the Aquilion PRIME 80 series an ideal system for routine clinical scanning or bariatric patient studies.
To reinforce the principle of As Low As Reasonably Achievable (ALARA) imaging, AIDR 3D and NEMA XR 25 Dose Check Software are standard features on the Aquilion PRIME 80 series. AIDR 3D, the newest dose-reduction technology for the Aquilion CT product line, is an iterative process that helps to remove noise from the image with reduced radiation dose. Toshiba’s NEMA XR 25 Dose Check Software enhances user awareness of the radiation dose being administered to patients. This software includes Dose Alert and Dose Notification, addressing the two main components of MITA’s CT Dose Check Initiative, as well as Tracking and Digital Imaging and Communications in Medicine (DICOM), to further enhance dose awareness.
“The PRIME 80 series is an example of how Toshiba constantly develops new technologies to improve safety in imaging and patient care,” said Tim Nicholson, senior manager, Market Development, CT Business Unit, Toshiba. “Giving hospitals the opportunity to conduct advanced exams in mere seconds and grow clinical abilities based on patient needs results in improved patient care and overall departmental efficiency.”
About Toshiba America Medical Systems, Inc.
With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.
Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems; and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).
Source: Toshiba America Medical Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.